Compare UBCP & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBCP | NSPR |
|---|---|---|
| Founded | 1902 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.4M | 81.8M |
| IPO Year | N/A | N/A |
| Metric | UBCP | NSPR |
|---|---|---|
| Price | $14.32 | $1.86 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 8.7K | ★ 59.6K |
| Earning Date | 02-06-2026 | 11-04-2025 |
| Dividend Yield | ★ 6.52% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.31 | N/A |
| Revenue | ★ $30,516,000.00 | $7,779,000.00 |
| Revenue This Year | N/A | $22.76 |
| Revenue Next Year | $5.59 | $75.45 |
| P/E Ratio | $10.95 | ★ N/A |
| Revenue Growth | 4.40 | ★ 14.04 |
| 52 Week Low | $12.25 | $1.59 |
| 52 Week High | $15.64 | $3.80 |
| Indicator | UBCP | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 44.27 |
| Support Level | $14.02 | $1.66 |
| Resistance Level | $14.39 | $2.15 |
| Average True Range (ATR) | 0.50 | 0.15 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 67.28 | 38.24 |
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.